Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate (Tydemy)
Questions a plan sponsor actually asks.
What is Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate used for?
Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate is tracked in Medicare Part D. Specific indication information is not available in our current dataset.
Is there a generic for Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate?
Yes. 4 ANDAs filed at FDA, 2 generic manufacturers currently shipping.
How much does my plan pay for Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate?
Across 329 Part D plans, Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate averages $2.17/unit (NADAC). Lowest available: $1.38/unit. Highest in distribution: $2.96/unit.
Is Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate on the FDA shortage list?
No. Drospirenone, Ethinyl Estradiol and Levomefolate and Levomefolate is not currently on the FDA Drug Shortage Database.
4 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (8 approvals on file) · NADAC unit costs: CMS NADAC weekly file (2 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.